SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-005420
Filing Date
2021-11-10
Accepted
2021-11-10 16:31:20
Documents
48
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phio_i10q-093021.htm   iXBRL 10-Q 791055
2 CERTIFICATION phio_10q-ex3101.htm EX-31.1 7463
3 CERTIFICATION phio_10q-ex3201.htm EX-32.1 3944
  Complete submission text file 0001683168-21-005420.txt   3824659

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phio-20210930.xsd EX-101.SCH 26805
5 XBRL CALCULATION FILE phio-20210930_cal.xml EX-101.CAL 36892
6 XBRL DEFINITION FILE phio-20210930_def.xml EX-101.DEF 100154
7 XBRL LABEL FILE phio-20210930_lab.xml EX-101.LAB 232171
8 XBRL PRESENTATION FILE phio-20210930_pre.xml EX-101.PRE 184037
9 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10q-093021_htm.xml XML 650335
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 211397171
SIC: 2834 Pharmaceutical Preparations